Expression of human leukocyte antigen‑G and acute rejection in patients following liver transplantation

Hu,Wei-Yu; Wu,Li-Qun; Su,Zhan; Pang,Xu-Feng; Zhang,Bin

doi:10.3892/etm.2014.1917

Expression of human leukocyte antigen‑G and acute rejection in patients following liver transplantation

Authors:
- Wei-Yu Hu
- Li-Qun Wu
- Zhan Su
- Xu-Feng Pang
- Bin Zhang
View Affiliations

Affiliations: Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Medical College, Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: August 19, 2014 https://doi.org/10.3892/etm.2014.1917
Pages: 1291-1295

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute liver rejection is one of the most severe complications that may affect the liver transplantation procedure. Thus, one of the most important focal points in the field of liver transplantation research is to discover a non‑invasive or less‑invasive method of diagnosing and predicting cases of acute liver rejection. In the present study, 59 tissue samples, including blood and liver tissues, were collected from patients who underwent liver transplantation between March 2005 and November 2009. The patients were divided into acute rejection and no rejection groups, the latter of which was further divided into normal and abnormal liver function groups. The samples were assayed by enzyme‑linked immunosorbent assay and immunohistochemistry methods. The results were analyzed and a receiver operating characteristic (ROC) curve was plotted. The area under the ROC curve and the sensitivity and specificity of the cut‑off point were analyzed statistically. The results indicated that the expression level of human leukocyte antigen‑G (HLA‑G) in the serum and liver samples in the acute rejection group was markedly lower than that in the no rejection group (P<0.001 and P=0.004, respectively). Furthermore, in the no rejection group, no statistically significant difference was identified in the level of HLA‑G between patients with normal or abnormal liver function (P=0.0593). The area under the ROC curve was 0.805. When 2.41 U/ml HLA‑G was considered as the cut‑off point for the diagnosis of acute liver rejection, the sensitivity and specificity were 72.7 and 83.8%, respectively. In conclusion, in the present study, a high expression of the HLA‑G was shown to correlate with a reduced occurrence of acute liver rejection. HLA‑G may thus be an effective factor for the diagnosis and prediction of acute liver rejection.

View Figures

View References

1	Hiramine Y, Uto H, Imamura Y, Tabu K, Baba Y, Hiwaki T, Sho Y, Tahara K, Higashi H, Tamai T, Oketani M, Ido A and Tsubouchi T: Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study. Exp Ther Med. 2:433–441. 2011.PubMed/NCBI
2	Curigliano G, Criscitiello C, Gelao L and Goldhirsch A: Molecular pathways: human leukocyte antigen G (HLA-G). Clin Cancer Res. 19:5564–5571. 2013. View Article : Google Scholar : PubMed/NCBI
3	No authors listed. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 25:658–663. 1997. View Article : Google Scholar : PubMed/NCBI
4	Fluss R, Faraggi D and Reiser B: Estimation of the Youden index and its associated cutoff point. Biom J. 47:458–472. 2005. View Article : Google Scholar : PubMed/NCBI
5	Carosella ED, Moreau P, Lemaoult J and Rouas-Freiss N: HLA-G: from biology to clinical benefits. Trends Immunol. 29:125–132. 2008. View Article : Google Scholar : PubMed/NCBI
6	Onichtchouk D, Chen TG, Dosch R, Gawantka V, Delius H, Massagué J and Niehrs C: Silencing of TGF-beta signalling by the pseudoreceptor BAMBI. Nature. 401:480–485. 1999. View Article : Google Scholar : PubMed/NCBI
7	Neumann UP, Langrehr JM, Lang M, Schmitz V, Menzel S, Steinmueller T and Neuhaus P: Impact of HLA matching upon outcome after liver transplantation. Transplant Proc. 34:1499–1500. 2002. View Article : Google Scholar : PubMed/NCBI
8	Baba Y, Sonoda JI, Hayashi S, Tosuji N, Sonoda S, Makisumi K and Nakajo M: Reduction of oxidative stress in liver cancer patients by oral green tea polyphenol tablets during hepatic arterial infusion chemotherapy. Exp Ther Med. 4:452–458. 2012.PubMed/NCBI
9	Başaran O, Ozcay F, Karakayali H, Turan M, Dalgiç A and Haberal M: Influence of HLA compatibility on success with living-related pediatric liver transplantation. Transplant Proc. 37:3151–3153. 2005.PubMed/NCBI
10	Contini P, Ghio M, Merlo A, Poggi A, Indiveri F and Puppo F: Apoptosis of antigen-specific T lymphocytes upon the engagement of CD8 by soluble HLA class I molecules is Fas ligand/Fas mediated: evidence for the involvement of p56lck, calcium calmodulin kinase II, and Calcium-independent protein kinase C signaling pathways and for NF-κB and NF-AT nuclear translocation. J Immunol. 175:7244–7254. 2005.PubMed/NCBI
11	Guillard C, Zidi I, Marcou C, Menier C, Carosella ED and Moreau P: Role of HLA-G in the innate immunity through direct activation of NF-κB in natural killer cells. Mol Immunol. 45:419–427. 2008.PubMed/NCBI
12	Bahri R, Hirsch F, Josse A, Rouua-Freiss N, Bidere N, Vasquez A, Carosella ED, Charpentier B and Durrbach A: Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol. 176:1331–1339. 2006. View Article : Google Scholar : PubMed/NCBI
13	Favier B, LeMaoult J, Rouas-Freiss N, Moreau P, Menier C and Carosella ED: Research on HLA-G: an update. Tissue Antigens. 69:207–211. 2007. View Article : Google Scholar : PubMed/NCBI
14	Liang S, Zhang W and Horuzsko A: Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur J Immunol. 36:2457–2471. 2006. View Article : Google Scholar : PubMed/NCBI
15	Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, Caumartin J, LeMaoult J, Carosella ED and Rouas-Freiss N: CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T cell subsets involved in transplant acceptance. Blood. 110:3936–3948. 2007. View Article : Google Scholar : PubMed/NCBI
16	Ma Y, Wang GD, He XS, Li JL, Zhu XF and Hu RD: Clinical and pathological analysis of acute rejection following orthotopic liver transplantation. Chin Med J (Engl). 22:1400–1403. 2009.PubMed/NCBI
17	LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A and Carosella ED: Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood. 109:2040–2048. 2007. View Article : Google Scholar : PubMed/NCBI
18	Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A and Wiendl H: HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation. Blood. 110:568–577. 2007. View Article : Google Scholar : PubMed/NCBI
19	Caumartin J, Favier B, Daouya M, Guillard C, Moreau P, Carosella ED and LeMaoult J: Trogocytosis-based generation of suppressive NK cells. EMBO J. 26:1423–1433. 2007. View Article : Google Scholar : PubMed/NCBI
20	Swets JA: Measuring the accurancy of diagnostic systems. Science. 240:1285–1293. 1998. View Article : Google Scholar